News and Events
New International Biosecurity Organization Launched to Safeguard Bioscience
IBBIS is a first-of-its-kind organization to strengthen international biosecurity governance.
News
-
February 15, 2024
IBBIS Executive Director chairs Biosecurity panel at SynbiTECH 2023
IBBIS Executive Director Dr. Piers Millett chaired the opening panel of SynbiTECH 2023 in London, UK on December 5
News
-
December 15, 2023
IBBIS Accepted to Paris Peace Forum Scale Up Program
IBBIS selected as one of 10 initiatives to receive support from the Paris Peace Forum community to accelerate its efforts to strengthen biosecurity norms.
News
-
December 1, 2023
Dr. Piers Millett on how the Scientific Community can Move Beyond Taxonomic Lists for Biosecurity
Dr. Piers Millett is a lead author on a journal article for Health Security that examines how the scientific community can begin to move past using lists of organisms for biosecurity controls.
Publication
-
October 20, 2023
Dr. Piers Millett Authors Editorial for Science Magazine
Dr. Piers Millett argues for greater safeguards to protect the dangerous pathogens kept in labs around the world in a new Science Magazine editorial.
Publication
-
October 19, 2023
IBBIS Highlighted in 2023 UK National Biological Security Strategy
The new UK Government Biological Security Strategy explicitly recognized the important role played by IBBIS and the importance of DNA synthesis screening.
Coverage
-
June 15, 2023
Millett Participates in OECD Global Forum on Technology
Dr. Millett participates in inaugural OECD Global Forum on Technology with more than 300 senior policymakers and leading technology experts to discuss "shaping our future at the tech frontier."
News
-
June 10, 2023
IBBIS at Biosecurity Innovation and Risk Reduction Initiative Annual Meeting
IBBIS Executive Director Piers Millett provided a progress update to the annual meeting of the Biosecurity Innovation and Risk Reduction Initiative.
News
-
June 5, 2023
Millett Outlines IBBIS Engagement with Industry at SynBioBeta 2023
IBBIS' Executive Director Piers Millett took to the main stage of the 2023 SynBioBeta Global Synthetic Biology Conference.
News
-
June 1, 2023
Piers Millett Discusses the Common Mechanism in Council on Strategic Risks Interview
Millett discusses the need for the international Common Mechanism and why IBBIS is well-positioned to develop this tool for DNA providers.
News
-
April 11, 2023
Addressing Catastrophic Biological Risks at the Munich Security Conference
IBBIS Executive Director Dr. Piers Millett joined global leaders in public health, biotechnology, and international security at NTI's side event at the 2023 Munich Security Conference.
News
-
February 22, 2023
Science | Business Article Makes the Case for IBBIS
Science | Business International Editor David Matthews explains how IBBIS will work with researchers, funders, and industry stakeholders.
Coverage
-
January 17, 2023
Biosecurity Solutions Offered at the Biological Weapons Convention Review Conference
IBBIS was the main feature in a side event during the 9th Review Conference of the Biological Weapons Convention (BWC) in Geneva, Switzerland.
News
-
December 15, 2022
IBBIS at 2022 Global Tech Summit as India Assumes the G20 Presidency
IBBIS Executive Director Dr. Piers Millett attended the 7th annual Global Technology Summit in New Delhi.
News
-
December 12, 2022
IBBIS introduced at G7 Global Partnership Working Group in Berlin
Dr. Piers Millett attended the G7 Global Partnership Against the Spread of Weapons and Materials of Mass Destruction Working Group and Conference on Biosecurity Challenges in Berlin, Germany on October 5, 2022.
News
-
October 9, 2022
Leading Experts Propose IBBIS to Promote Stronger Global Biosecurity Norms
Margaret Hamburg, Jaime Yassif, Hayley Severance and R. Alta Charo propose the establishment of IBBIS to reduce biosecurity risks.
Publication
-
February 9, 2022
Plans to Establish IBBIS Cited in Testimony at U.S. House Hearing on “Biosecurity for the Future: Strengthening Deterrence and Detection”
Plans to establish IBBIS were described in a testimony to a U.S. House Foreign Affairs Subcommittee.
Testimony
-
December 8, 2021